What is the debt of Vaxcyte this year?
Vaxcyte has a debt level of -397.45 USD this year.
Vaxcyte Debt 2024
Vaxcyte Debt
-397.45 USD
Ticker
PCVX
ISIN
US92243G1085
WKN
A2P6R6
In 2024, Vaxcyte's total debt was -397.45 USD, a -52.38% change from the -834.7 USD total debt recorded in the previous year.
Vaxcyte Aktienanalyse
What does Vaxcyte do?
Vaxcyte Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of vaccines for various diseases. The company was founded in 2018 and is headquartered in Foster City, California. Vaxcyte ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding Vaxcyte's Debt Structure
Vaxcyte's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing Vaxcyte's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to Vaxcyte’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in Vaxcyte’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about Vaxcyte stock
What was the debt of Vaxcyte compared to the previous year?
The debt of Vaxcyte has increased by -52.38% compared to the previous year dropped.
What are the consequences of high debt for investors in Vaxcyte?
High debt can pose a risk for investors of Vaxcyte, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of Vaxcyte?
Low debt means that Vaxcyte has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from Vaxcyte affect the company?
An increase in debt of Vaxcyte can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of Vaxcyte affect the company?
A reduction in debt of Vaxcyte can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of Vaxcyte?
Some factors that can influence the debt of Vaxcyte include investments, acquisitions, operating costs, and revenue development.
Why are the debts of Vaxcyte so important for investors?
The debts of Vaxcyte are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can Vaxcyte take to change the debt?
To change the debt, Vaxcyte can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does Vaxcyte pay?
Over the past 12 months, Vaxcyte paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Vaxcyte is expected to pay a dividend of 0 USD.
What is the dividend yield of Vaxcyte?
The current dividend yield of Vaxcyte is .
When does Vaxcyte pay dividends?
Vaxcyte pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Vaxcyte?
Vaxcyte paid dividends every year for the past 0 years.
What is the dividend of Vaxcyte?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Vaxcyte located?
Vaxcyte is assigned to the 'Health' sector.
Wann musste ich die Aktien von Vaxcyte kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Vaxcyte from 9/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/28/2024.
When did Vaxcyte pay the last dividend?
The last dividend was paid out on 9/28/2024.
What was the dividend of Vaxcyte in the year 2023?
In the year 2023, Vaxcyte distributed 0 USD as dividends.
In which currency does Vaxcyte pay out the dividend?
The dividends of Vaxcyte are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Vaxcyte
Our stock analysis for Vaxcyte Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vaxcyte Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
